Andoza:Serotonin receptor modulators: Versiyalar orasidagi farq
Qiyofa
# | {{#invoke:navbox|navbox | ||
| name = Serotonin receptor modulators | |||
| title = [[5-HT receptor|Serotonin receptor]] [[receptor modulator|modulator]]s | |||
| state = {{{state<includeonly>|collapsed</includeonly>}}} | |||
| bodyclass = hlist | |||
| groupstyle = text-align:center; | |||
| border = {{{border|}}}<!-- for embedding in [[Template:Monoaminergics]] --> | |||
{{R | | group1 = [[5-HT1 receptor|5-HT<sub>1</sub>]] | ||
| list1 = {{#invoke:navbox|navbox|child | |||
| groupstyle = text-align:center; | |||
| group1 = [[5-HT1A receptor|5-HT<sub>1A</sub>]] | |||
| list1 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[Adatanserin]] | |||
* [[Amphetamine]] | |||
* [[Antidepressant]]s (e.g., [[etoperidone]], [[hydroxynefazodone]], [[nefazodone]], [[trazodone]], [[triazoledione]], [[vilazodone]], [[vortioxetine]]) | |||
* [[AP-521]] | |||
* [[Atypical antipsychotic]]s (e.g., [[aripiprazole]], [[asenapine]], [[brexpiprazole]], [[cariprazine]], [[clozapine]], [[elopiprazole]], [[lurasidone]], [[perospirone]], [[quetiapine]], [[tiospirone]], [[umespirone]], [[ziprasidone]]) | |||
* [[Azapirone]]s (e.g., [[alnespirone]], [[binospirone]], [[BMY-7378]], [[buspirone]], [[enilospirone]], [[eptapirone|eptapirone (F-11440)]], [[gepirone]], [[ipsapirone]], [[perospirone]], [[revospirone]], [[tandospirone]], [[tiospirone]], [[umespirone]], [[zalospirone]]) | |||
* [[Befiradol|Befiradol (NLX-112; F-13640)]] | |||
* [[Bifeprunox]] | |||
* [[BMY-14802|BMY-14802 (BMS-181100)]] | |||
* [[Cannabidiol]] | |||
* [[Dimemebfe]] | |||
* [[Dopamine]] | |||
* [[DSP-0038]] | |||
* [[DSP-1181]] | |||
* [[Di-β-phenylisopropylamine|DPIA]] | |||
* [[Ebalzotan]] | |||
* [[Eltoprazine]] | |||
* [[Enciprazine]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[bromocriptine]], [[cabergoline]], [[dihydroergotamine]], [[ergotamine]], [[lisuride]], [[LSD]], [[Methylergometrine|methylergometrine (methylergonovine)]], [[methysergide]], [[pergolide]]) | |||
* [[F-8910-RS]] | |||
* [[F-11461]] | |||
* [[F-12826]] | |||
* [[F-13714]] | |||
* [[F-14679]] | |||
* [[F-15063]] | |||
* [[F-15599|F-15599 (NLX-101)]] | |||
* [[F-17464]] | |||
* [[FKW00GA|FKW00GA (TGW00AA)]] | |||
* [[Flesinoxan]] | |||
* [[Flibanserin]] | |||
* [[Flumexadol]] | |||
* [[Hypidone]] | |||
* [[Lesopitron]] | |||
* [[LY-315712]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | |||
* [[Naftopidil]] | |||
* [[Naluzotan]] | |||
* [[NBUMP]] | |||
* [[NLX-204]] | |||
* [[NLX-266]] | |||
* [[Osemozotan|Osemozotan (MKC-242)]] | |||
* [[Oxaflozane]] | |||
* [[Pardoprunox]] | |||
* [[Partial ergoline]]s (e.g., [[6-MeO-RU-28306]], [[8-OH-DPAT]], [[LY-178210|LY-178210 (LY-228729)]], [[Bay R 1531|Bay R 1531 (LY-197206)]], [[FHATHBIN]], [[LY-293284]], [[LY-301317]], [[RU-28306]], [[U-92016A|U-92016A (U92016A)]]) | |||
* [[Piclozotan]] | |||
* [[Piromelatine]] | |||
* [[Rauwolscine]] | |||
* [[Repinotan]] | |||
* [[Roxindole]] | |||
* [[RU-24969]] | |||
* [[S-14506]] | |||
* [[S-14671]] | |||
* [[S-15535]] | |||
* [[Sarizotan]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[SKL-PSY|SKL-PSY (FZ-016)]] | |||
* [[SSR-181507]] | |||
* [[SUN-8399]] | |||
* [[Sunepitron]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[4-F-5-MeO-pyr-T]], [[5-carboxamidotryptamine|5-CT]], [[5-MeO-DMT]], [[5-MeO-pip-T]], [[5-MeO-pyr-T]], [[5-methoxytryptamine|5-MT]], [[bufotenin]], [[dimethyltryptamine|DMT]], [[GR-46611]], [[indorenate]], [[N-methylserotonin|N-Me-5-HT]], [[psilocin]], [[psilocybin]]) | |||
* [[TGBA01AD|TGBA01AD (FKB01MD)]] | |||
* [[TGFK-09SD|TGFK-09SD (TGFK09SD)]] | |||
* [[TMU4142]] | |||
* [[TZB-30878]] | |||
* [[Ulotaront]] | |||
* [[Urapidil]] | |||
* [[VML-670|VML-670 (CEB-1555)]] | |||
* [[Xaliproden]] | |||
* [[Yohimbine]] | |||
| list2 = | |||
* ''Positive allosteric modulators:'' [[Cannabicyclol|Cannabicyclol (CBL)]] | |||
* [[Oleamide]] | |||
| list3 = | |||
* ''Antagonists:'' [[Atypical antipsychotic]]s (e.g., [[iloperidone]], [[risperidone]], [[sertindole]]) | |||
* [[AV965]] | |||
* [[AZD-3676]] | |||
* [[Beta blocker]]s (e.g., [[alprenolol]], [[carteolol]], [[cyanopindolol]], [[iodocyanopindolol]], [[isamoltane]], [[oxprenolol]], [[penbutolol]], [[pindobind]], [[pindolol]], [[propranolol]], [[tertatolol]]) | |||
* [[BMY-7378]] | |||
* [[CSP-2503]] | |||
* [[Dotarizine]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[metergoline]]) | |||
* [[Flopropione]] | |||
* [[GSK-958108]] | |||
* [[Lecozotan]] | |||
* [[LY-206130]] | |||
* [[LY-297996|LY-297996 ((–)-LY206130)]] | |||
* [[LY-426965]] | |||
* [[Mefway (18F)|Mefway]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[MIN-117|MIN-117 (WF-516)]] | |||
* [[MPPF]] | |||
* [[NAN-190]] | |||
* [[Robalzotan]] | |||
* [[S-15535]] | |||
* [[SB-272183]] | |||
* [[SB-649915]] | |||
* [[SDZ 216-525]] | |||
* [[Spiperone]] | |||
* [[Spiramide]] | |||
* [[Spiroxatrine]] | |||
* [[UH-301|UH-301 ((''S'')-5-FHDPAT)]] | |||
* [[WAY-100135]] | |||
* [[WAY-100635]] | |||
* [[Xylamidine]] | |||
| list4 = | |||
* ''Unknown/unsorted:'' [[Acetryptine]] | |||
* [[Carvedilol]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[Ergometrine|ergometrine (ergonovine)]]) | |||
}} | |||
| group2 = [[5-HT1B receptor|5-HT<sub>1B</sub>]] | |||
| list2 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[(S)-DCPT|(''S'')-DCPT]] | |||
* [[Alniditan]] | |||
* [[Anpirtoline]] | |||
* [[AZ10419369]] | |||
* [[Substituted benzofuran|Benzofuran]]s (e.g., [[5-MAPB]], [[6-MAPB]], [[BK-5-MAPB]], [[BK-6-MAPB]]) | |||
* [[Substituted benzothiophene|Benzothiophene]]s (e.g., [[5-MAPBT]], [[6-MAPBT]], [[BK-5-MAPBT]]) | |||
* [[CGS-12066|CGS-12066 (CGS-12066A, CGS-12066B)]] | |||
* [[CP-93129]] | |||
* [[CP-94253]] | |||
* [[CP-122288]] | |||
* [[CP-135807]] | |||
* [[Eltoprazine]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[bromocriptine]], [[dihydroergotamine]], [[ergotamine]], [[Methylergometrine|methylergometrine (methylergonovine)]], [[methysergide]], [[pergolide]]) | |||
* [[GR-46611]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | |||
* [[Substituted methylenedioxyphenethylamine|Methylenedioxyphenethylamine]]s (e.g., [[MDMA]], [[methylone]]) | |||
* [[PGI-7043]] | |||
* [[PZKKN-94]] | |||
* [[RU-24969]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Triptan]]s (e.g., [[avitriptan]], [[donitriptan]], [[eletriptan]], [[IS-159]], [[sumatriptan]], [[zolmitriptan]]) | |||
* [[Trifluoromethylphenylpiperazine|TFMPP]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-benzyloxytryptamine|5-BT]], [[5-carboxamidotryptamine|5-CT]], [[5-methoxytryptamine|5-MT]], [[dimethyltryptamine|DMT]]) | |||
* [[Vortioxetine]] | |||
| list2 = | |||
* ''Antagonists:'' [[AOP-208|AOP-208 (LB-208)]] | |||
* [[AR-A000002]] | |||
* [[AZD-3676]] | |||
* [[Beta blocker]]s (e.g., [[alprenolol]], [[carteolol]], [[isamoltane]], [[oxprenolol]], [[penbutolol]], [[propranolol]], [[tertatolol]]) | |||
* [[Elzasonan]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[metergoline]]) | |||
* [[F-12682]] | |||
* [[F-14258]] | |||
* [[GR-127935]] | |||
* [[LY-393558]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[SB-216641]] | |||
* [[SB-224289]] | |||
* [[SB-236057]] | |||
* [[SB-272183]] | |||
* [[SB-616234]] | |||
* [[Trelanserin]] | |||
* [[Yohimbine]] | |||
| list3 = | |||
* ''Negative allosteric modulators:'' [[5-HT-moduline]] | |||
| list4 = | |||
* ''Miscellaneous:'' [[HG1 (drug)|HG1]] (5-HT-moduline antagonist) | |||
| list5 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[cabergoline]], [[Ergometrine|ergometrine (ergonovine)]], [[lisuride]]) | |||
}} | |||
| group3 = [[5-HT1D receptor|5-HT<sub>1D</sub>]] | |||
| list3 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[Alniditan]] | |||
* [[CGS-12066|CGS-12066 (CGS-12066A, CGS-12066B)]] | |||
* [[CP-122288]] | |||
* [[CP-135807]] | |||
* [[CP-286601]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[bromocriptine]], [[cabergoline]], [[dihydroergotamine]], [[ergotamine]], [[LSD]], [[methysergide]]) | |||
* [[GR-46611]] | |||
* [[L-694247]] | |||
* [[L-772405]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | |||
* [[Piromelatine]] | |||
* [[PNU-109291]] | |||
* [[PNU-142633]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[TGBA01AD|TGBA01AD (FKB01MD)]] | |||
* [[Triptan]]s (e.g., [[almotriptan]], [[avitriptan]], [[donitriptan]], [[eletriptan]], [[frovatriptan]], [[IS-159]], [[naratriptan]], [[rizatriptan]], [[sumatriptan]], [[zolmitriptan]]) | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-benzyloxytryptamine|5-BT]], [[5-carboxamidotryptamine|5-CT]], [[5-ethyl-DMT|5-Et-DMT]], [[5-methoxytryptamine|5-MT]], [[5-(nonyloxy)tryptamine]], [[dimethyltryptamine|DMT]]) | |||
| list2 = | |||
* ''Antagonists:'' [[BRL-15572]] | |||
* [[Elzasonan]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[metergoline]]) | |||
* [[F-12682]] | |||
* [[F-14258]] | |||
* [[GR-127935]] | |||
* [[Ketanserin]] | |||
* [[LY-310762]] | |||
* [[LY-367642]] | |||
* [[LY-393558]] | |||
* [[LY-456219]] | |||
* [[LY-456220]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Mianserin]] | |||
* [[Ritanserin]] | |||
* [[SB-272183]] | |||
* [[Yohimbine]] | |||
* [[Ziprasidone]] | |||
| list3 = | |||
* ''Negative allosteric modulators:'' [[5-HT-moduline]] | |||
| list4 = | |||
* ''Unknown/unsorted:'' [[Acetryptine]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[lisuride]], [[lysergol]], [[pergolide]]) | |||
}} | |||
| group4 = [[5-HT1E receptor|5-HT<sub>1E</sub>]] | |||
| list4 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[BRL-54443]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[methysergide]]) | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Triptan]]s (e.g., [[eletriptan]]) | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[tryptamine]]) | |||
| list2 = | |||
* ''Antagonists:'' [[Metitepine|Metitepine (methiothepin)]] | |||
| list3 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[Ergometrine|ergometrine (ergonovine)]], [[lysergol]], [[Methylergometrine|methylergometrine (methylergonovine)]] | |||
}} | |||
| group5 = [[5-HT1F receptor|5-HT<sub>1F</sub>]] | |||
| list5 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[BRL-54443]] | |||
* [[CP-122288]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[bromocriptine]], [[lysergol]], [[Methylergometrine|methylergometrine (methylergonovine)]] [[methysergide]]) | |||
* [[Lasmiditan]] | |||
* [[LY-334370]] | |||
* [[LY-344864]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Triptan]]s (e.g., [[eletriptan]], [[naratriptan]], [[sumatriptan]]) | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-Methoxytryptamine|5-MT]]) | |||
| list2 = | |||
* ''Antagonists:'' [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Mianserin]] | |||
| list3 = | |||
* ''Unknown/unsorted:'' [[LY-53857]] | |||
* [[LY-86057]] | |||
}} | |||
}} | |||
| group2 = [[5-HT2 receptor|5-HT<sub>2</sub>]] | |||
| list2 = {{#invoke:navbox|navbox|child | |||
| groupstyle = text-align:center; | |||
| group1 = [[5-HT2A receptor|5-HT<sub>2A</sub>]] | |||
| list1 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' 25H/NB series (e.g., [[25I-NBF]], [[25I-NBMD]], [[25I-NBOH]], [[25I-NBOMe]], [[25B-NBOMe]], [[25C-NBOMe]], [[25TFM-NBOMe]], [[2CBCB-NBOMe]], [[25CN-NBOH]], [[2CBFly-NBOMe]], [[BMB-202]]) | |||
* [[2C (psychedelics)|2Cs]] (e.g., [[2C-B]], [[2C-E]], [[2C-I]], [[2C-T-2]], [[2C-T-7]], [[2C-T-21]]) | |||
* [[2C-B-FLY]] | |||
* [[2CB-Ind]] | |||
* [[5-Methoxytryptamine]]s ([[5-MeO-DET]], [[5-Methoxy-N,N-diisopropyltryptamine|5-MeO-DiPT]], [[5-MeO-DMT]], [[5-MeO-DPT]], [[5-Methoxytryptamine|5-MT]]) | |||
* [[Substituted alpha-alkyltryptamine|α-Alkyltryptamine]]s (e.g., [[5-Chloro-αMT|5-Cl-αMT]], [[5-Fluoro-AMT|5-Fl-αMT]], [[5-MeO-AET|5-MeO-αET]], [[5-MeO-aMT|5-MeO-αMT]], [[Alpha-Methylserotonin|α-Me-5-HT]], [[Alpha-Ethyltryptamine|αET]], [[Alpha-Methyltryptamine|αMT]]) | |||
* [[AL-34662]] | |||
* [[AL-37350A]] | |||
* [[Aporphine]]s and [[noraporphine]]s (e.g., [[glaucine|(''S'')-glaucine]], [[11-methoxyasimilobine]], [[2-hydroxy-11-(2-methylallyl)oxynoraporphine]]) | |||
* [[BMB-201]] | |||
* [[Bromo-DragonFLY]] | |||
* [[Dimemebfe]] | |||
* [[DMBMPP]] | |||
* [[DOx]] (e.g., [[2,5-Dimethoxy-4-bromoamphetamine|DOB]], [[2,5-Dimethoxy-4-chloroamphetamine|DOC]], [[2,5-Dimethoxy-4-iodoamphetamine|DOI]], [[2,5-Dimethoxy-4-methylamphetamine|DOM]]) | |||
* [[Efavirenz]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[1P-LSD]], [[ALD-52]], [[bromocriptine]], [[cabergoline]], [[ergine|ergine (LSA)]], [[ergometrine|ergometrine (ergonovine)]], [[ergotamine]], [[lisuride]], [[Lysergic acid 2,4-dimethylazetidide|LA-SS-Az]], [[Lysergic acid 2-butyl amide|LSB]], [[LSD]], [[LSD-Pip]], [[Lysergic acid hydroxyethylamide|LSH]], [[Lysergic acid 3-pentyl amide|LSP]], [[Methylergometrine|methylergometrine (methylergonovine)]], [[pergolide]]) | |||
* [[Flumexadol]] | |||
* [[IHCH-7113]] | |||
* [[IHCH-8110]] | |||
* [[Jimscaline]] | |||
* [[Lorcaserin]] | |||
* [[Substituted methylenedioxyphenethylamine|MDxx]] (e.g., [[3,4-Methylenedioxyamphetamine|MDA (tenamfetamine)]], [[MDMA|MDMA (midomafetamine)]], [[3,4-Methylenedioxy-N-hydroxyamphetamine|MDOH]], [[MMDA (drug)|MMDA]]) | |||
* [[O-4310]] | |||
* [[Oxaflozane]] | |||
* [[PHA-57378]] | |||
* [[PNU-22394]] | |||
* [[PNU-181731]] | |||
* [[RH-34]] | |||
* [[SCHEMBL5334361]] | |||
* [[Substituted phenethylamine|Phenethylamines]] (e.g., [[lophophine]], [[mescaline]]) | |||
* [[Piperazine]]s (e.g., [[Benzylpiperazine|BZP]], [[quipazine]], [[Trifluoromethylphenylpiperazine|TFMPP]], [[VCU-1012]]) | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[TCB-2]] | |||
* [[TFMFly]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-benzyloxytryptamine|5-BT]], [[5-carboxamidotryptamine|5-CT]], [[bufotenin]], [[diethyltryptamine|DET]], [[diisopropyltryptamine|DiPT]], [[dimethyltryptamine|DMT]], [[dipropyltryptamine|DPT]], [[psilocin]], [[psilocybin]], [[tryptamine]]) | |||
* [[UH-232]] | |||
| list2 = | |||
* ''Positive allosteric modulators:'' [[AB0124]] | |||
* [[CTW0404]] | |||
* [[CTW0419]] | |||
* [[JPC0323]] | |||
* [[(R)-Glaucine|(''R'')-Glaucine]] | |||
* [[Oleamide]] | |||
| list3 = | |||
* ''Antagonists:'' [[4F-4PP]] | |||
* [[5-I-R91150]] | |||
* [[5-MeO-NBpBrT]] | |||
* [[AC-90179]] | |||
* [[Adatanserin]] | |||
* [[Altanserin]] | |||
* [[Antihistamine]]s (e.g., [[cyproheptadine]], [[hydroxyzine]], [[ketotifen]], [[perlapine]]) | |||
* [[9-Aminomethyl-9,10-dihydroanthracene|AMDA]] | |||
* [[Atypical antipsychotic]]s (e.g., [[amperozide]], [[aripiprazole]], [[asenapine]], [[blonanserin]], [[brexpiprazole]], [[carpipramine]], [[clocapramine]], [[clorotepine]], [[clozapine]], [[fluperlapine]], [[gevotroline]], [[iloperidone]], [[lurasidone]], [[melperone]], [[mosapramine]], [[ocaperidone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[sertindole]], [[zicronapine]], [[ziprasidone]], [[zotepine]]) | |||
* [[Barettin]] | |||
* [[Butanserin]] | |||
* [[Chlorprothixene]] | |||
* [[Cinanserin]] | |||
* [[CSP-2503]] | |||
* [[Deramciclane]] | |||
* [[DLX-2270]] | |||
* [[Dotarizine]] | |||
* [[DSP-0038]] | |||
* [[DSP-6745]] | |||
* [[Eplivanserin]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[amesergide]], [[LY-53857]], [[LY-215840]], [[mesulergine]], [[metergoline]], [[methysergide]], [[sergolexole]]) | |||
* [[Fananserin]] | |||
* [[FCE-24379]] | |||
* [[FKW00GA|FKW00GA (TGW00AA)]] | |||
* [[Flibanserin]] | |||
* [[Glemanserin]] | |||
* [[Irindalone]] | |||
* [[KB-128]] | |||
* [[Ketanserin]] | |||
* [[KML-010]] | |||
* [[Landipirdine]] | |||
* [[LY03017]] | |||
* [[LY-393558]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | |||
* [[Medifoxamine]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Metrenperone]] | |||
* [[MIN-117|MIN-117 (WF-516)]] | |||
* [[MT-1207]] | |||
* [[Naftidrofuryl]] | |||
* [[Nantenine]] | |||
* [[Nelotanserin]] | |||
* [[NH130]] | |||
* [[Opiranserin|Opiranserin (VVZ-149)]] | |||
* [[Pelanserin]] | |||
* [[Phenoxybenzamine]] | |||
* [[Pimavanserin]] | |||
* [[Pirenperone]] | |||
* [[Pizotifen]] | |||
* [[Pruvanserin]] | |||
* [[R-96544]] | |||
* [[R-102444]] | |||
* [[Rauwolscine]] | |||
* [[Ritanserin]] | |||
* [[Roluperidone]] | |||
* [[S-14671]] | |||
* [[SpAMDA]] | |||
* [[Sarpogrelate]] | |||
* [[Seganserin]] | |||
* [[Serotonin antagonist and reuptake inhibitor|Serotonin antagonists and reuptake inhibitors]] (e.g., [[etoperidone]], [[hydroxynefazodone]], [[lubazodone]], [[mepiprazole]], [[nefazodone]], [[triazoledione]], [[trazodone]]) | |||
* [[Temanogrel]] | |||
* [[Teniloxazine]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[aptazapine]], [[esmirtazapine]], [[maprotiline]], [[mianserin]], [[mirtazapine]]) | |||
* [[TGBA01AD|TGBA01AD (FKB01MD)]] | |||
* [[Trelanserin]] | |||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]]) | |||
* [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[fluphenazine]], [[haloperidol]], [[loxapine]], [[perphenazine]], [[pimozide]], [[pipamperone]], [[prochlorperazine]], [[setoperone]], [[spiperone]], [[spiramide]], [[thioridazine]], [[Tiotixene|thiothixene]], [[trifluoperazine]]) | |||
* [[Volinanserin]] | |||
* [[Xylamidine]] | |||
* [[Yohimbine]] | |||
| list4 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[dihydroergotamine]], [[nicergoline]]) | |||
}} | |||
| group2 = [[5-HT2B receptor|5-HT<sub>2B</sub>]] | |||
| list2 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[4-Methylaminorex]] | |||
* [[Aminorex]] | |||
* [[Substituted amphetamine|Amphetamines]] (e.g., [[chlorphentermine]], [[cloforex]], [[dexfenfluramine]], [[fenfluramine]], [[levofenfluramine]], [[norfenfluramine]]) | |||
* [[BW-723C86]] | |||
* [[DOx]] (e.g., [[2,5-Dimethoxy-4-bromoamphetamine|DOB]], [[2,5-Dimethoxy-4-chloroamphetamine|DOC]], [[2,5-Dimethoxy-4-iodoamphetamine|DOI]], [[2,5-Dimethoxy-4-methylamphetamine|DOM]]) | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[cabergoline]], [[dihydroergocryptine]], [[dihydroergotamine]], [[ergotamine]], [[Methylergometrine|methylergometrine (methylergonovine)]], [[methysergide]], [[pergolide]]) | |||
* [[Lorcaserin]] | |||
* [[Substituted methylenedioxyphenethylamine|MDxx]] (e.g., [[3,4-Methylenedioxyamphetamine|MDA (tenamfetamine)]], [[MDMA|MDMA (midomafetamine)]], [[3,4-Methylenedioxy-N-hydroxyamphetamine|MDOH]], [[MMDA (drug)|MMDA]]) | |||
* [[Substituted piperazine|Piperazine]]s (e.g., [[trifluoromethylphenylpiperazine|TFMPP]]) | |||
* [[PNU-22394]] | |||
* [[Ro60-0175]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-benzyloxytryptamine|5-BT]], [[5-carboxamidotryptamine|5-CT]], [[5-methoxytryptamine|5-MT]], [[α-methylserotonin|α-Me-5-HT]], [[bufotenin]], [[diethyltryptamine|DET]], [[diisopropyltryptamine|DiPT]], [[dimethyltryptamine|DMT]], [[dipropyltryptamine|DPT]], [[psilocin]], [[psilocybin]], [[tryptamine]]) | |||
| list2 = | |||
* ''Antagonists:'' [[1-Methylmedmain]] | |||
* [[Agomelatine]] | |||
* [[Atypical antipsychotic]]s (e.g., [[amisulpride]], [[aripiprazole]], [[asenapine]], [[brexpiprazole]], [[cariprazine]], [[clozapine]], [[N-desalkylquetiapine|''N''-desalkylquetiapine (norquetiapine)]], [[Desmethylclozapine|''N''-desmethylclozapine (norclozapine)]], [[olanzapine]], [[pipamperone]], [[quetiapine]], [[risperidone]], [[ziprasidone]]) | |||
* [[Cyproheptadine]] | |||
* [[EGIS-7625]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[amesergide]], [[bromocriptine]], [[lisuride]], [[LY-53857]], [[LY-272015]], [[mesulergine]]) | |||
* [[IHCH-8110]] | |||
* [[KB-128]] | |||
* [[Ketanserin]] | |||
* [[LY-393558]] | |||
* [[Meta-Chlorophenylpiperazine|mCPP]] | |||
* [[Medmain]] | |||
* [[Metadoxine]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Minaprine]] | |||
* [[MRS8209]] | |||
* [[MW073]] | |||
* [[Pirenperone]] | |||
* [[Piromelatine]] | |||
* [[Pizotifen]] | |||
* [[Propranolol]] | |||
* [[PRX-08066]] | |||
* [[Rauwolscine]] | |||
* [[Ritanserin]] | |||
* [[RS-127445]] | |||
* [[Sarpogrelate]] | |||
* [[SB-200646]] | |||
* [[SB-204741]] | |||
* [[SB-206553]] | |||
* [[SB-215505]] | |||
* [[SB-221284]] | |||
* [[SB-228357]] | |||
* [[SDZ SER-082]] | |||
* [[Tegaserod]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[mianserin]], [[mirtazapine]]) | |||
* [[Trazodone]] | |||
* [[Typical antipsychotic]]s (e.g., [[chlorpromazine]]) | |||
* [[TIK-301]] | |||
* [[Yohimbine]] | |||
| list3 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[Ergometrine|ergometrine (ergonovine)]]) | |||
}} | |||
| group3 = [[5-HT2C receptor|5-HT<sub>2C</sub>]] | |||
| list3 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[2C (psychedelics)|2Cs]] (e.g., [[2C-B]], [[2C-E]], [[2C-I]], [[2C-T-2]], [[2C-T-7]], [[2C-T-21]]) | |||
* [[5-Methoxytryptamine]]s ([[5-MeO-DET]], [[5-Methoxy-N,N-diisopropyltryptamine|5-MeO-DiPT]], [[5-MeO-DMT]], [[5-MeO-DPT]], [[5-Methoxytryptamine|5-MT]]) | |||
* [[Substituted alpha-alkyltryptamine|α-Alkyltryptamine]]s (e.g., [[5-Chloro-αMT|5-Cl-αMT]], [[5-Fluoro-AMT|5-Fl-αMT]], [[5-MeO-AET|5-MeO-αET]], [[5-MeO-aMT|5-MeO-αMT]], [[Alpha-Methylserotonin|α-Me-5-HT]], [[Alpha-Ethyltryptamine|αET]], [[Alpha-Methyltryptamine|αMT]]) | |||
* [[A-372159]] | |||
* [[AL-38022A]] | |||
* [[Alstonine]] | |||
* [[Aporphine]]s and [[noraporphine]]s (e.g., [[MQ02-439]], [[glaucine|(''S'')-glaucine]], [[nornuciferine]], [[asimilobine]], [[11-chloroasimilobine]], [[11-methoxyasimilobine]]) | |||
* [[ATHX-105]] | |||
* [[Bexicaserin]] | |||
* [[BMB-101]] | |||
* [[BMB-105]] | |||
* [[BMB-201]] | |||
* [[Centhaquine]] | |||
* [[CP-809101]] | |||
* [[Dimemebfe]] | |||
* [[DLX-2270]] | |||
* [[DOx]] (e.g., [[2,5-Dimethoxy-4-bromoamphetamine|DOB]], [[2,5-Dimethoxy-4-chloroamphetamine|DOC]], [[2,5-Dimethoxy-4-iodoamphetamine|DOI]], [[2,5-Dimethoxy-4-methylamphetamine|DOM]]) | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[ALD-52]], [[cabergoline]], [[dihydroergotamine]], [[Ergine|ergine (LSA)]], [[ergotamine]], [[lisuride]], [[Lysergic acid 2,4-dimethylazetidide|LA-SS-Az]], [[Lysergic acid 2-butyl amide|LSB]], [[LSD]], [[LSD-Pip]], [[Lysergic acid hydroxyethylamide|LSH]], [[Lysergic acid 3-pentyl amide|LSP]], [[pergolide]]) | |||
* [[Flumexadol]] | |||
* [[IHCH-8110]] | |||
* [[KB-128]] | |||
* [[Lorcaserin]] | |||
* [[Lumocaserin]] | |||
* [[LY03020]] | |||
* [[Substituted methylenedioxyphenethylamine|MDxx]] (e.g., [[3,4-Methylenedioxyamphetamine|MDA (tenamfetamine)]], [[MDMA|MDMA (midomafetamine)]], [[3,4-Methylenedioxy-N-hydroxyamphetamine|MDOH]], [[MMDA (drug)|MMDA]]) | |||
* [[MK-212]] | |||
* [[ORG-12962]] | |||
* [[ORG-37684]] | |||
* [[Oxaflozane]] | |||
* [[PHA-57378]] | |||
* [[Substituted phenethylamine|Phenethylamines]] (e.g., [[lophophine]], [[mescaline]]) | |||
* [[Piperazine]]s (e.g., [[aripiprazole]], [[Benzylpiperazine|BZP]], [[Meta-Chlorophenylpiperazine|mCPP]], [[quipazine]], [[Trifluoromethylphenylpiperazine|TFMPP]]) | |||
* [[PNU-22394]] | |||
* [[PNU-181731]] | |||
* [[PRX-00933|PRX-00933 (BVT-933; GW-876167)]] | |||
* [[Ro60-0175]] | |||
* [[Ro60-0213]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-benzyloxytryptamine|5-BT]], [[5-carboxamidotryptamine|5-CT]], [[bufotenin]], [[diethyltryptamine|DET]], [[diisopropyltryptamine|DiPT]], [[dimethyltryptamine|DMT]], [[dipropyltryptamine|DPT]], [[psilocin]], [[psilocybin]], [[tryptamine]], [[CPI-CG-8]]) | |||
* [[Vabicaserin]] | |||
* [[VR-1065]] | |||
* [[WAY-629]] | |||
* [[WAY-161503]] | |||
* [[YM-348]] | |||
| list2 = | |||
* ''Positive allosteric modulators:'' [[CTW0415]] | |||
* [[CYD-1-79]] | |||
* [[JPC0323]] | |||
* [[Oleamide]] | |||
* [[PNU-69176E]] | |||
* [[VA012]] | |||
* [[VA240 (drug)|VA240]] | |||
| list3 = | |||
* ''Antagonists:'' [[Adatanserin]] | |||
* [[Agomelatine]] | |||
* [[Atypical antipsychotic]]s (e.g., [[asenapine]], [[clorotepine]], [[clozapine]], [[fluperlapine]], [[iloperidone]], [[melperone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[sertindole]], [[ziprasidone]], [[zotepine]]) | |||
* [[Captodiame]] | |||
* [[6-Chloro-5-ethoxy-N-(pyridin-2-yl)indoline-1-carboxamide|CEPC]] | |||
* [[Cinanserin]] | |||
* [[Cyproheptadine]] | |||
* [[Deramciclane]] | |||
* [[Desmetramadol]] | |||
* [[Dotarizine]] | |||
* [[DSP-6745]] | |||
* [[Eltoprazine]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[amesergide]], [[bromocriptine]], [[LY-53857]], [[LY-215840]], [[mesulergine]], [[metergoline]], [[methysergide]], [[sergolexole]]) | |||
* [[Etoperidone]] | |||
* [[Fluoxetine]] | |||
* [[FR260010]] | |||
* [[Irindalone]] | |||
* [[Ketanserin]] | |||
* [[Ketotifen]] | |||
* [[Latrepirdine|Latrepirdine (dimebolin)]] | |||
* [[LY03017]] | |||
* [[Medifoxamine]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Nefazodone]] | |||
* [[Pirenperone]] | |||
* [[Pizotifen]] | |||
* [[Propranolol]] | |||
* [[Ritanserin]] | |||
* [[RS-102221]] | |||
* [[S-14671]] | |||
* [[SB-200646]] | |||
* [[SB-206553]] | |||
* [[SB-221284]] | |||
* [[SB-228357]] | |||
* [[SB-242084]] | |||
* [[SB-243213]] | |||
* [[SB-247853]] | |||
* [[SDZ SER-082]] | |||
* [[Seganserin]] | |||
* [[Tedatioxetine]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[aptazapine]], [[esmirtazapine]], [[maprotiline]], [[mianserin]], [[mirtazapine]]) | |||
* [[TIK-301]] | |||
* [[Tramadol]] | |||
* [[Trazodone]] | |||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[nortriptyline]]) | |||
* [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[loxapine]], [[pimozide]], [[pipamperone]], [[thioridazine]]) | |||
* [[Xylamidine]] | |||
| list4 = | |||
* ''Unknown/unsorted:'' [[Efavirenz]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[Ergometrine|ergometrine (ergonovine)]], [[Methylergometrine|methylergometrine (methylergonovine)]]) | |||
}} | |||
}} | |||
| group3 = [[5-HT3 receptor|5-HT<sub>3</sub>]]<sub>–[[5-HT7 receptor|7]]</sub> | |||
| list3 = {{#invoke:navbox|navbox|child | |||
| groupstyle = text-align:center; | |||
| group1 = [[5-HT3 receptor|5-HT<sub>3</sub>]] | |||
| list1 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[Alcohol (chemistry)|Alcohol]]s (e.g., [[N-Butanol|butanol]], [[alcohol (drug)|ethanol (alcohol)]], [[2,2,2-Trichloroethanol|trichloroethanol]]) | |||
* [[Chlorophenylbiguanide|m-CPBG]] | |||
* [[Phenylbiguanide]] | |||
* [[Piperazine]]s (e.g., [[Benzylpiperazine|BZP]], [[Meta-Chlorophenylpiperazine|mCPP]], [[quipazine]]) | |||
* [[RS-56812]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[SR-57227]] | |||
* [[SR-57227A]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[2-Methyl-5-hydroxytryptamine|2-Me-5-HT]], [[5-Carboxamidotryptamine|5-CT]], [[Bufotenidine|bufotenidine (5-HTQ)]]) | |||
* [[Inhalational anaesthetic|Volatiles/gases]] (e.g., [[halothane]], [[isoflurane]], [[toluene]], [[1,1,1-Trichloroethane|trichloroethane]]) | |||
* [[YM-31636]] | |||
| list2 = | |||
* ''Positive allosteric modulators:'' [[5-Aminoindole]] | |||
* [[5-Chloroindole]] | |||
* [[5-Hydroxyindole]] | |||
* [[Catechol]] | |||
* [[Chloroform]] | |||
* [[Chlorophenylbiguanide|''meta''-Chlorophenylbiguanide (mCPBG)]] | |||
* [[Colchicine]]<!-- Low concentrations --> | |||
* [[Ethanol]] ([[alcohol (drug)|alcohol]]) | |||
* [[Halothane]] | |||
* [[Indole]] | |||
* [[Isoflurane]] | |||
* [[Trans-3-(4-methoxyphenyl)-N-(pentan-3-yl)acrylamide|TMPPAA]] | |||
| list3 = | |||
* ''Antagonists:'' [[Alosetron]] | |||
* [[Anpirtoline]] | |||
* [[Arazasetron]] | |||
* [[AS-8112]] | |||
* [[Atypical antipsychotic]]s (e.g., [[clozapine]], [[olanzapine]], [[quetiapine]]) | |||
* [[Azasetron]] | |||
* [[Batanopride]] | |||
* [[Bemesetron|Bemesetron (MDL-72222)]] | |||
* [[Cilansetron]] | |||
* [[CSP-2503]] | |||
* [[Dazopride]] | |||
* [[Dolasetron]] | |||
* [[Galanolactone]] | |||
* [[Granisetron]] | |||
* [[Itasetron]] | |||
* [[Lerisetron]] | |||
* [[Memantine]] | |||
* [[Ondansetron]] | |||
* [[Palonosetron]] | |||
* [[Ramosetron]] | |||
* [[Renzapride]] | |||
* [[Ricasetron]] | |||
* [[Tedatioxetine]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[mianserin]], [[mirtazapine]]) | |||
* [[Thujone]] | |||
* [[Tropanserin]] | |||
* [[Tropisetron]] | |||
* [[Typical antipsychotic]]s (e.g., [[loxapine]]) | |||
* [[TZB-30878]] | |||
* [[Inhalational anaesthetic|Volatiles/gases]] (e.g., [[nitrous oxide]], [[sevoflurane]], [[xenon]]) | |||
* [[Vortioxetine]] | |||
* [[Zacopride]] | |||
* [[Zatosetron]] | |||
| list4 = | |||
* ''Negative allosteric modulators:'' [[Bupropion]] | |||
* [[Colchicine]]<!-- High concentrations --> | |||
* [[Hydroxybupropion]] | |||
| list5 = | |||
* ''Unknown/unsorted:'' [[Piperazine]]s (e.g., [[naphthylpiperazine]]) | |||
}} | |||
| group2 = [[5-HT4 receptor|5-HT<sub>4</sub>]] | |||
| list2 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[5-Methoxytryptamine|5-MT]] | |||
* [[BIMU8]] | |||
* [[Capeserod]] | |||
* [[Cinitapride]] | |||
* [[Cisapride]] | |||
* [[CJ-033466]] | |||
* [[Dazopride]] | |||
* [[Metoclopramide]] | |||
* [[Minesapride]] | |||
* [[Mosapride]] | |||
* [[Prucalopride]] | |||
* [[PRX-03140]] | |||
* [[Renzapride]] | |||
* [[RS-67333]] | |||
* [[RS-67506]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Tegaserod]] | |||
* [[Usmarapride]] | |||
* [[Velusetrag]] | |||
* [[Zacopride]] | |||
| list2 = | |||
* ''Antagonists:'' [[GR-113808]] | |||
* [[GR-125487]] | |||
* [[Lysine|L-Lysine]] | |||
* [[Piboserod]] | |||
* [[RS-39604]] | |||
* [[RS-67532]] | |||
* [[SB-203186]] | |||
* [[SB-204070]] | |||
}} | |||
| group3 = [[5-HT5A receptor|5-HT<sub>5A</sub>]] | |||
| list3 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[Substituted ergoline|Ergoline]]s (e.g., [[2-Bromo-LSD|2-Br-LSD (BOL-148)]], [[ergotamine]], [[LSD]]) | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-Carboxamidotryptamine|5-CT]]) | |||
* [[UCSF648]] | |||
* [[Valerenic acid]] | |||
| list2 = | |||
* ''Antagonists:'' [[Asenapine]] | |||
* [[Latrepirdine|Latrepirdine (dimebolin)]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Ritanserin]] | |||
* [[SB-699551]] | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[metergoline]], [[methysergide]]) | |||
* [[Piperazine]]s (e.g., [[naphthylpiperazine]]) | |||
}} | |||
| group4 = [[5-HT6 receptor|5-HT<sub>6</sub>]] | |||
| list4 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[Substituted ergoline|Ergoline]]s (e.g., [[dihydroergocryptine]], [[dihydroergotamine]], [[ergotamine]], [[lisuride]], [[LSD]], [[mesulergine]], [[metergoline]], [[methysergide]]) | |||
* [[Hypidone]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[2-Methyl-5-hydroxytryptamine|2-Me-5-HT]], [[5-Benzyloxytryptamine|5-BT]], [[5-Carboxamidotryptamine|5-CT]], [[5-Methoxytryptamine|5-MT]], [[Bufotenin]], [[E-6801]], [[E-6837]], [[EMD-386088]], [[EMDT]], [[LY-586713]], [[N-Methyl-5-HT|N-Me-5-HT]], [[ST-1936]], [[tryptamine]]) | |||
* [[WAY-181187]] | |||
* [[WAY-208466]] | |||
| list2 = | |||
* ''Antagonists:'' [[ABT-354]] | |||
* [[Atypical antipsychotic]]s (e.g., [[aripiprazole]], [[asenapine]], [[clorotepine]], [[clozapine]], [[fluperlapine]], [[iloperidone]], [[olanzapine]], [[tiospirone]]) | |||
* [[AVN-101]] | |||
* [[AVN-211]] | |||
* [[AVN-322]] | |||
* [[AVN-397]] | |||
* [[BGC20-760]] | |||
* [[BVT-5182]] | |||
* [[BVT-74316]] | |||
* [[Cerlapirdine]] | |||
* [[EGIS-12233]] | |||
* [[GW-742457]] | |||
* [[Idalopirdine]] | |||
* [[Ketanserin]] | |||
* [[Landipirdine]] | |||
* [[Latrepirdine|Latrepirdine (dimebolin)]] | |||
* [[Masupirdine]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[MS-245]] | |||
* [[PRX-07034]] | |||
* [[PZKKN-94]] | |||
* [[Ritanserin]] | |||
* [[Ro 04-6790]] | |||
* [[Ro 63-0563]] | |||
* [[SB-258585]] | |||
* [[SB-271046]] | |||
* [[SB-357134]] | |||
* [[SB-399885]] | |||
* [[Intepirdine|SB-742457]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[mianserin]]) | |||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[clomipramine]], [[doxepin]], [[nortriptyline]]) | |||
* [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[loxapine]]) | |||
| list3 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[2-Bromo-LSD|2-Br-LSD (BOL-148)]], [[bromocriptine]], [[lergotrile]], [[pergolide]]) | |||
* [[Piperazine]]s (e.g., [[naphthylpiperazine]]) | |||
}} | |||
| group5 = [[5-HT7 receptor|5-HT<sub>7</sub>]] | |||
| list5 = {{#invoke:navbox|navbox|child | |||
| list1 = | |||
* ''Agonists:'' [[8-OH-DPAT]] | |||
* [[AS-19 (drug)|AS-19]] | |||
* [[Bifeprunox]] | |||
* [[E-55888]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[LSD]]) | |||
* [[LP-12]] | |||
* [[LP-44]] | |||
* [[LP-211]] | |||
* [[RU-24969]] | |||
* [[Sarizotan]] | |||
* [[Serotonin|Serotonin (5-HT)]] | |||
* [[Triptan]]s (e.g., [[frovatriptan]]) | |||
* [[Substituted tryptamine|Tryptamines]] (e.g., [[5-Carboxamidotryptamine|5-CT]], [[5-Methoxytryptamine|5-MT]], [[bufotenin]], [[N-Methylserotonin|N-Me-5-HT]]) | |||
| list2 = | |||
* ''Antagonists:'' [[Atypical antipsychotic]]s (e.g., [[amisulpride]], [[aripiprazole]], [[asenapine]], [[brexpiprazole]], [[clorotepine]], [[clozapine]], [[fluperlapine]], [[olanzapine]], [[risperidone]], [[sertindole]], [[tiospirone]], [[ziprasidone]], [[zotepine]]) | |||
* [[Butaclamol]] | |||
* [[DR-4485]] | |||
* [[DSP-6745]] | |||
* [[EGIS-12233]] | |||
* [[Substituted ergoline|Ergoline]]s (e.g., [[2-Bromo-LSD|2-Br-LSD (BOL-148)]], [[amesergide]], [[bromocriptine]], [[cabergoline]], [[dihydroergotamine]], [[ergotamine]], [[LY-53857]], [[LY-215840]], [[mesulergine]], [[metergoline]], [[methysergide]], [[sergolexole]]) | |||
* [[JNJ-18038683]] | |||
* [[Ketanserin]] | |||
* [[LY-215840]] | |||
* [[Metitepine|Metitepine (methiothepin)]] | |||
* [[Ritanserin]] | |||
* [[SB-258719]] | |||
* [[SB-258741]] | |||
* [[SB-269970]] | |||
* [[SB-656104]] | |||
* [[SB-656104A]] | |||
* [[SB-691673]] | |||
* [[SLV-313]] | |||
* [[SLV-314]] | |||
* [[Spiperone]] | |||
* [[SSR-181507]] | |||
* [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[maprotiline]], [[mianserin]], [[mirtazapine]]) | |||
* [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[clomipramine]], [[imipramine]]) | |||
* [[Typical antipsychotic]]s (e.g., [[acetophenazine]], [[chlorpromazine]], [[chlorprothixene]], [[fluphenazine]], [[loxapine]], [[pimozide]]) | |||
* [[Vortioxetine]] | |||
| list3 = | |||
* ''Negative allosteric modulators:'' [[Oleamide]] | |||
| list4 = | |||
* ''Unknown/unsorted:'' [[Substituted ergoline|Ergoline]]s (e.g., [[lisuride]], [[pergolide]]) | |||
* [[Piperazine]]s (e.g., [[naphthylpiperazine]]) | |||
}} | |||
}} | |||
| below = | |||
* '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]'' | |||
* ''[[Template:Adrenergic receptor modulators|Adrenergics]]'' | |||
* ''[[Template:Dopamine receptor modulators|Dopaminergics]]'' | |||
* ''[[Template:Melatonin receptor modulators|Melatonergics]]'' | |||
* ''[[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]] and [[Template:Monoamine releasing agents|releasing agents]]'' | |||
* ''[[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]]'' | |||
* ''[[Template:Monoamine neurotoxins|Monoamine neurotoxins]]'' | |||
}}<noinclude> | |||
{{Documentation}} | |||
</noinclude> | |||
2026-yil 21-avgust, 17:33 dagi (joriy) koʻrinishi
| Tajriba oʻtkazish uchun qumloq va test sahifasidan foydalaning. Iltimos, turkumlarni hujjat sahifasiga va intervikilarni vikimaʼlumotlarga joylashtiring. Ushbu andoza ostsahifalari. |